Table 2.

Comparison of laboratory data at diagnosis.

PTU-induced AAV, n = 36Primary AAV, n = 174p
ANCA by immunofluorescence
  p-ANCA, n (%)34 (94.4)137 (78.7)
  c-ANCA, n (%)1 (2.8)37 (21.3)< 0.05
  Atypical ANCA, n (%)1 (2.8)0
ANCA by ELISA
  MPO-ANCA only, n (%)31 (86.1)137 (78.7)
  PR3-ANCA only, n (%)1 (2.8)37 (21.3)NS
  PR3-ANCA + MPO-ANCA, n (%)4 (11.1)0
Anemia, n (%)15 (41.7)146 (83.9)< 0.01
Immunology, n (%)
  ANA positivity12 (33.3)18 (10.3)< 0.01
  ENA positivity3 (8.3)3 (1.7)NS
  IgG increased8 (22.2)54 (31.0)NS
  IgA increased3 (8.3)34 (19.5)NS
  IgE increased3 (8.3)29 (16.7)NS
  IgM increased7 (19.4)5 (2.9)< 0.01
  C3 decreased3 (8.3)41 (23.6)NS
  C4 decreased1 (2.8)21 (12.1)NS
  ESR increased24 (66.7)124 (71.3)NS
  CRP increased13 (36.1)94 (54.0)NS
  • ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; ANA: antinuclear antibodies; ENA: extractable nuclear antigens; ANCA: antineutrophil cytoplasmic antibody; PTU: propylthiouracil; AAV: ANCA-associated vasculitis; MPO: myeloperoxidase; PR3: proteinase 3; NS: nonsignificant.